Table 2 Adherence outcomes by intervention and assessment period
Pre-Tx | Mid-Tx | Post-Tx | Follow-Up | |
|---|---|---|---|---|
M (SD) | M (SD) | M (SD) | M (SD) | |
CPS-C | n = 11a | n = 10 | n = 11 | n = 10 |
VAS Previous Week | – | – | – | – |
VAS1w | 70.09 (33.18) | 88.10 (19.11) | 91.27 (8.70) | 94.00 (7.67) |
VAS2w | 78.36 (31.44) | 91.20 (13.64) | 95.36 (6.53) | 93.50 (10.10) |
VAS3w | 59.73 (34.39) | 80.00 (24.90) | 86.55 (17.58) | 91.78 (11.97) |
VAS Previous Month | – | – | – | – |
VAS1m | 67.82 (31.66) | 90.25 (20.44) | 89.91 (14.68) | 92.20 (10.47) |
VAS2m | 68.60 (29.76) | 88.89 (22.74) | 90.91 (15.12) | 91.80 (9.90) |
VAS3m | 62.09 (30.62) | 82.80 (22.04) | 89.82 (16.28) | 91.90 (9.93) |
MEMS Cap Percentage | – | 52.00 (43.50) | 40.75 (47.14) | 22.75 (39.12) |
CPS-T | n = 12 | n = 10 | n = 10 | n = 10 |
VAS Previous Week | – | – | – | – |
VAS1w | 77.67 (29.66) | 89.67 (17.46) | 84.80 (31.07) | 85.00 (30.02) |
VAS2w | 82.50 (30.11) | 84.11 (32.69) | 86.20 (31.30) | 87.60 (30.39) |
VAS3w | 80.00 (30.15) | 78.89 (33.98) | 86.80 (31.22) | 88.80 (29.36) |
VAS Previous Month | – | – | – | – |
VAS1m | 72.67 (31.72) | 78.50 (31.86) | 79.40 (30.04) | 83.40 (30.70) |
VAS2m | 75.83 (31.68) | 83.20 (22.85) | 81.10 (30.27) | 85.30 (31.19) |
VAS3m | 75.42 (32.85) | 82.50 (20.17) | 82.30 (30.49) | 85.20 (31.22) |
MEMS Cap Percentage | – | 32.67 (17.90) | 11.67 (12.01) | 4.67 (2.52) |
ATR | n = 10 | n = 10 | n = 8 | n = 8 |
VAS Previous Week | – | – | – | – |
VAS1w | 66.00 (29.64) | 82.80 (25.32) | 68.75 (39.03) | 82.13 (23.09) |
VAS2w | 68.00 (35.62) | 83.40 (21.69) | 68.13 (38.96) | 81.75 (23.62) |
VAS3w | 72.70 (31.71) | 82.11 (19.98) | 65.63 (39.46) | 81.88 (22.00) |
VAS Previous Month | – | – | – | – |
VAS1m | 60.50 (34.18) | 81.80 (23.71) | 65.88 (37.75) | 80.13 (24.10) |
VAS2m | 65.70 (35.47) | 81.70 (23.94) | 63.13 (36.75) | 81.25 (24.42) |
VAS3m | 64.10 (35.45) | 81.80 (22.74) | 64.63 (35.81) | 81.63 (24.39) |
MEMS Cap Percentage | – | 51.67 (29.02) | 14.33 (11.24) | 2.67 (2.08) |